Chronic Kidney Disease and Hypertensive-Related Complications of Elevated Fibroblast Growth Factor 23
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 24, Issue 4
Abstract
Chronic Kidney Disease (CKD) affects more than 10% of the world population. Treatment methods such as dialysis or transplantation are expensive. Among different factors responsible for the cause and progression of CKD are diabetes mellitus and hypertension. Hypertension is also a consequence of CKD. According to studies, hypertension is highly prevalent among patients with CKD and becomes more severe as the disease progresses. Fibroblast growth factor 23 (FGF-23) is an hormone which is a major regulator of phosphate balance. Vascular dysfunction and hypertension are among the various cardiovascular diseases (CVDs) associated with CKD. Reports suggest that the development of vascular dysfunction and hypertension is mediated by elevated FGF-23 levels in CKD. FGF-23 causes: renin-angiotensin-aldosterone system (RAAS) activation, plasma volume expansion due to aldosterone activities and increased expression of Na+Cl- Co-transporter (NCC) in the renal distal tubule, increased vascular resistance due to the vascular effects of angiotensin II and free radicals. All of which independently result in the development of hypertension in CKD. In opposition, RAAS inhibition prevents vascular smooth muscle contraction. It has been found in both experimental and human studies that RAAS inhibition may restore renal klotho, which may directly and indirectly improve kidney function and protect the cardiovascular system during CKD. Also, chlorothiazide, an inhibitor of NCC function, decreases blood volume and consequently prevents volume-induced hypertension. Furthermore, treatment with antioxidant agents to scavenge and reduce reactive oxygen species (ROS) or superoxide decreases vascular reactivity, hence, reduces or prevent oxidative stress. Also, oxidative stress is reduced or prevented through caloric restriction and calorie-restriction mimetics which reduce the generation of ROS by stabilizing mitochondrial energy production and efficiency. This review focuses on the role of elevated FGF-23 complications in the development of hypertension in CKD, and how these complications could be ameliorated. In conclusion, this review recommends treatment of hypertension that targets reduction or prevention of elevated FGF-23 complications in CKD and increased klotho expression to prevent CKD progression.
Authors and Affiliations
O. O. Omodara, P. P. Mshelia, M. I. A. Saleh, A. A. Madaki
Keywords
Related Articles
- EP ID EP312461
- DOI 10.9734/JAMMR/2017/36967
- Views 72
- Downloads 0
Small Cell Lung Carcinoma with Overt Cutaneous Metastasis; Unusual Case
Small cell lung carcinoma is a rapidly progressive neuroendocrine tumor having a poor prognosis. It is considered as a systemic disease, because it has diffuse involvement, distant organ metastasis, and regional lymphati...
Family Risk of Metabolic Disorder; A Parameter for Timely Screening of Vascular Endothelial Health
Aim: To study the correlation of vascular endothelial health with family risk of metabolic disorders, in healthy overweight, obese and non obese subjects. Study Design: A case-control (pilot) study. Place and Duration o...
Prevalence and Pattern of Impacted Teeth in the North-East China
Aims: To investigate the prevalence and pattern of impacted teeth in the sample of North-East China. Study Design: Descriptive and Retrospective study. Place and Duration of Study: School of Stomatology, Department of...
Eye Care Service Utilization among Health Workers in Mercy Hospital, Abak
Background: The assessment of the level of and barriers to utilization of eye care services is paramount in combating visual impairment and blindness which are major health problems worldwide. Objectives: To determine th...
Basic Fibroblast Growth Factor (bFGF), Fibroblast Growth Factor Receptor 1 (FGFR1), Transforming Growth Factor Beta (TGF-β) and Chromogranin A (CgA) Appearance in Congenital Intra-abdominal Adhesions in Children under One Year of Age
Aim: Of this work was to determine dispersion of TGF-b, fibrosis modulating factor (bFGF and FGR1) and granule marker chromogranin A in case of intra-abdominal adhesion which could be essential factors in disease pathoge...